Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05746078 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Performance and Safety Assessment of SPRING THREAD® Elastic Tensor Thread in Patients With Mild to Moderate Facial Ptosis.

Study acronym: ESTES
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date changed from estimate of Mar 2025 to Feb 7, 2026 Show 5 more changesShow less
    • Enrollment closed, study ongoing
    • Study completion pushed from Mar 2029 to Dec 2030
    • Study sites: 3 to 2
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: details revised at 3 of 5 entries
  2. Primary completion date: Feb 16, 2023 to Mar 2025
    • Study sites: 4 to 3
    • Study completion date: Jul 1, 2028 to Mar 2029
    v3
  3. Study sites: 2 to 4
    • Eligibility criteria revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this post-market clinical follow up study is to assess the safety and effectiveness of the SPRING THREAD® elastic tensor thread. The study will evaluate the outcome of the SPRING THREAD® elastic tensor thread range over a period of 5 years.
Trial Details
NCT Number NCT05746078
Lead Sponsor 1st SurgiConcept
Collaborators: EVAMED
Conditions
(from sponsor)		 Ptosis, Ptosis, Mild
Related terms Blepharoptosis, Lymphoma, Follicular
Enrollment 99 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov